We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-17.54%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$30.3B
AUM Growth
-$3.58B
Cap. Flow
+$2.33B
Cap. Flow %
7.68%
Top 10 Hldgs %
8.23%
Holding
3,177
New
628
Increased
764
Reduced
970
Closed
730

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$297M
2
BAC icon
Bank of America
BAC
+$249M
3
ORCL icon
Oracle
ORCL
+$247M
4
MSFT icon
Microsoft
MSFT
+$246M
5
SNAP icon
Snap
SNAP
+$243M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$260M
2
MRK icon
Merck
MRK
+$260M
3
SPGI icon
S&P Global
SPGI
+$233M
4
OXY icon
Occidental Petroleum
OXY
+$221M
5
WMT icon
Walmart Inc
WMT
+$211M

Sector Composition

Rank Sector Weight
1 Technology 19.21%
2 Healthcare 13.54%
3 Financials 11.06%
4 Industrials 10.41%
5 Consumer Discretionary 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UROY
2251
Uranium Royalty Corp
UROY
$1.67B
$96K ﹤0.01%
42,124
-18,500
-31% -$59.4K
REKR icon
2252
Rekor Systems
REKR
$80.3M
$95K ﹤0.01%
54,108
-16,192
-23% -$46.2K
TGB
2253
Trekor Metals
TGB
$3.42B
$95K ﹤0.01%
88,413
-1,064,323
-92% -$1.82M
IMRX icon
2254
Immuneering
IMRX
$335M
$93K ﹤0.01%
17,138
-34,222
-67% -$183K
KLTR icon
2255
Kaltura
KLTR
$249M
$91K ﹤0.01%
45,822
-40,571
-47% -$69.4K
INFI
2256
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$90K ﹤0.01%
143,098
-258,179
-64% -$198K
MAGN
2257
Magnera Corp
MAGN
$443M
$89K ﹤0.01%
+997
New +$120K
FTH
2258
Faeth Therapeutics
FTH
$897M
$88K ﹤0.01%
1,939
-1,170
-38% -$43.8K
STIM icon
2259
Neuronetics
STIM
$220M
$88K ﹤0.01%
27,508
-992
-3% -$2.88K
FABC
2260
Fabric.AI Inc
FABC
$19.9M
$87K ﹤0.01%
807
-1,480
-65% -$191K
HCWB icon
2261
HCW Biologics
HCWB
$4.24M
$87K ﹤0.01%
165
-48
-23% -$27K
AIRG icon
2262
Airgain
AIRG
$68.4M
$86K ﹤0.01%
10,600
-9,216
-47% -$83K
MDXG icon
2263
MiMedx Group
MDXG
$622M
$86K ﹤0.01%
24,704
-173,235
-88% -$678K
SGLY icon
2264
Singularity Future Technology
SGLY
$2.27M
$86K ﹤0.01%
+202
New +$165K
VBIV
2265
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$86K ﹤0.01%
3,554
-3,289
-48% -$112K
TESS
2266
DELISTED
Tessco Technologies Inc
TESS
$84K ﹤0.01%
14,236
-29,521
-67% -$177K
ATOS icon
2267
Atossa Therapeutics
ATOS
$26.3M
$83K ﹤0.01%
5,049
-32,184
-86% -$507K
TCON
2268
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$83K ﹤0.01%
2,064
-2,061
-50% -$79.8K
ERNA icon
2269
Eterna Therapeutics
ERNA
$5.88M
$81K ﹤0.01%
21
+16
+320% +$115K
NXTC icon
2270
NextCure
NXTC
$27M
$81K ﹤0.01%
+1,441
New +$75.3K
BCEL
2271
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$80K ﹤0.01%
+44,925
New +$93.9K
ATCX
2272
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$80K ﹤0.01%
15,216
-55,900
-79% -$529K
GBIO
2273
DELISTED
Generation Bio
GBIO
$79K ﹤0.01%
1,200
-10,292
-90% -$673K
VINC
2274
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$79K ﹤0.01%
3,004
-1,257
-30% -$55.9K
HMTV
2275
DELISTED
Hemisphere Media Group, Inc.
HMTV
$78K ﹤0.01%
+10,266
New +$59.7K

Similar funds

John Overdeck's Q2 2022 Portfolio in Review

As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $260M trimmed.

  • John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
  • John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
  • John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
  • John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
  • John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
  • John Overdeck opened 628 new positions and closed 730 in Q2 2022.
  • John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.